BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35795985)

  • 1. FOXO3a‑modulated DEPDC1 promotes malignant progression of nephroblastoma via the Wnt/β‑catenin signaling pathway.
    Geng G; Li Q; Guo X; Ni Q; Xu Y; Ma Z; Wang Y; Ming M
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35795985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.
    Qian C; Liu Q
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A16 cooperates with DEPDC1 to promote the progression and angiogenesis of nephroblastoma through PI3K/Akt/mTOR pathway.
    Geng G; Xu Y; Li Q; Li Q; Yuan L; Dong M; Ming M
    Pol J Pathol; 2023; 74(3):182-193. PubMed ID: 37955537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DEP Domain Containing 1 Promotes Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Enhancing Expression of Suppressor of Zest 12.
    Wang Q; Jiang S; Liu J; Ma G; Zheng J; Zhang Y
    Cancer Biother Radiopharm; 2021 Feb; 36(1):36-44. PubMed ID: 32343606
    [No Abstract]   [Full Text] [Related]  

  • 5. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.
    Yang M; Zhang H; Gao S; Huang W
    J Orthop Surg Res; 2023 Feb; 18(1):145. PubMed ID: 36849972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor HOXB2 upregulates NUSAP1 to promote the proliferation, invasion and migration of nephroblastoma cells via the PI3K/Akt signaling pathway.
    Luo B; Feng S; Li T; Wang J; Qi Z; Zhao Y; Hu B
    Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35485274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.
    Zhou C; Wang P; Tu M; Huang Y; Xiong F; Wu Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPDC1 up-regulates RAS expression to inhibit autophagy in lung adenocarcinoma cells.
    Wang W; Li A; Han X; Wang Q; Guo J; Wu Y; Wang C; Huang G
    J Cell Mol Med; 2020 Nov; 24(22):13303-13313. PubMed ID: 33021072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway.
    Cui FC; Chen Y; Wu XY; Hu M; Qin WS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4212-4223. PubMed ID: 32373957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer.
    Huang L; Chen K; Cai ZP; Chen FC; Shen HY; Zhao WH; Yang SJ; Chen XB; Tang GX; Lin X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):707-712. PubMed ID: 28634077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.
    Zhang L; Du Y; Xu S; Jiang Y; Yuan C; Zhou L; Ma X; Bai Y; Lu J; Ma J
    Cancer Lett; 2019 Feb; 442():242-251. PubMed ID: 30419349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR‑192‑5p upregulation mediates the suppression of curcumin in human NSCLC cell proliferation, migration and invasion by targeting c‑Myc and inactivating the Wnt/β‑catenin signaling pathway.
    Pan Y; Sun Y; Liu Z; Zhang C
    Mol Med Rep; 2020 Aug; 22(2):1594-1604. PubMed ID: 32626956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
    Qu D; Cui F; Lu D; Yang Y; Xu Y
    Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
    Shen J; Xi M
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):453-460. PubMed ID: 34134185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA
    Xu W; Wang J; Xu J; Li S; Zhang R; Shen C; Xie M; Zheng B; Gu M
    J Int Med Res; 2022 Apr; 50(4):3000605221093135. PubMed ID: 35466755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma.
    Yang Y; Jiang Y; Jiang M; Zhang J; Yang B; She Y; Wang W; Deng Y; Ye Y
    Exp Mol Pathol; 2016 Apr; 100(2):344-52. PubMed ID: 26970279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling.
    Wen Q; Jiao X; Kuang F; Hou B; Zhu Y; Guo W; Sun G; Ba Y; Yu D; Wang D; Zhang F; Qiao HC; Wang S; Tang S; Qiao H
    EBioMedicine; 2019 Feb; 40():198-209. PubMed ID: 30738830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells.
    Kikuchi R; Sampetrean O; Saya H; Yoshida K; Toda M
    J Neurooncol; 2017 Jun; 133(2):297-307. PubMed ID: 28555424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.